CAM2056 showed weight and A1c reductions comparable to or exceeding those seen for weekly semaglutide (Wegovy®) Results include a 9.3% weight reduction with CAM2056 vs. 5.2% with weekly semaglutide at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback